Modulari-T was founded to harness the power of modular immune receptors and build an evolved and differentiated version of cell and gene therapies. We are a venture backed preclinical-stage biotechnology company developing the next generation of in vivo cell and gene therapies from the in-depth understanding of the natural modulatory power of native immune receptors.
| Website | https://modularit.bio |
| Employees | 11 (9 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Gene Therapy, Regenerative Medicine, Gene Editing, Immunotherapy, Cell Engineering, Platform Technology, Crispr, Car T Cell Therapy, Oncolytic Virus, Bioprocessing, Precision Medicine, Drug Development, Pharmaceutical Manufacturing, Biotechnology, Therapeutics, Clinical Trials, Medical Technology |
| Competitors | Zymergen, Inc., Amgen, Geno, Synthace, Arzeda, Pivot Bio, Agenus, Shubham Agriculture Industries LLP, LanzaTech, Codexis, Inc. +33 more (view full list) |
Looking for a particular Modulari-T Bio employee's phone or email?
Etienne Gagnon is the Co-Founder and CSO of Modulari-T Bio.
9 people are employed at Modulari-T Bio.
Modulari-T Bio is based in Montreal, Quebec.